MX2013010831A - Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga. - Google Patents
Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga.Info
- Publication number
- MX2013010831A MX2013010831A MX2013010831A MX2013010831A MX2013010831A MX 2013010831 A MX2013010831 A MX 2013010831A MX 2013010831 A MX2013010831 A MX 2013010831A MX 2013010831 A MX2013010831 A MX 2013010831A MX 2013010831 A MX2013010831 A MX 2013010831A
- Authority
- MX
- Mexico
- Prior art keywords
- methods
- bone health
- infants
- fatty acids
- long chain
- Prior art date
Links
- 230000037180 bone health Effects 0.000 title abstract 3
- 238000000034 method Methods 0.000 title abstract 3
- 235000020978 long-chain polyunsaturated fatty acids Nutrition 0.000 title 1
- 230000037118 bone strength Effects 0.000 abstract 1
- 238000009472 formulation Methods 0.000 abstract 1
- 230000006651 lactation Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 230000011164 ossification Effects 0.000 abstract 1
- 230000035935 pregnancy Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
- A23L33/22—Comminuted fibrous parts of plants, e.g. bagasse or pulp
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pediatric Medicine (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Botany (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physical Education & Sports Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Se describen los métodos para mejorar la salud, la resistencia y la formación óseas en un bebé que puede ser susceptible a los problemas de la salud ósea que se desarrollan desde la procreación hasta la adolescencia. Los métodos incluyen administrar una formulación nutricional que incluye por lo menos un LCPUFA a una mujer durante el embarazo y opcionalmente durante la lactancia y el amamantamiento de un bebé.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP11380021A EP2502506A1 (en) | 2011-03-21 | 2011-03-21 | Methods for improving bone health in infants using long chain polyunsaturated fatty acids |
PCT/US2012/029796 WO2012129222A1 (en) | 2011-03-21 | 2012-03-20 | Methods for improving bone health in infants using long chain polyunsaturated fatty acids |
Publications (1)
Publication Number | Publication Date |
---|---|
MX2013010831A true MX2013010831A (es) | 2013-11-18 |
Family
ID=44343642
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2013010831A MX2013010831A (es) | 2011-03-21 | 2012-03-20 | Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga. |
Country Status (8)
Country | Link |
---|---|
US (1) | US20120245121A1 (es) |
EP (1) | EP2502506A1 (es) |
CN (1) | CN103533853A (es) |
BR (1) | BR112013024189A2 (es) |
CA (1) | CA2829794A1 (es) |
IL (1) | IL228339A0 (es) |
MX (1) | MX2013010831A (es) |
WO (1) | WO2012129222A1 (es) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NZ720946A (en) | 2009-04-29 | 2017-09-29 | Amarin Pharmaceuticals Ie Ltd | Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same |
MX2011011538A (es) | 2009-04-29 | 2012-06-13 | Amarin Pharma Inc | Composicion farmaceutica estable y metodos de uso de la misma. |
SI3318255T1 (sl) | 2009-06-15 | 2021-07-30 | Amarin Pharmaceuticals Ireland Limited | Kompozicije in metode za zdravljenje kapi pri subjektu, ki prejema sočasno zdravljenje s statinom |
CA2775339C (en) | 2009-09-23 | 2017-03-28 | Amarin Corporation Plc | Pharmaceutical composition comprising omega-3 fatty acid and hydroxy-derivative of a statin and methods of using same |
AU2011336856A1 (en) | 2010-11-29 | 2013-07-04 | Amarin Pharmaceuticals Ireland Limited | Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity |
US11291643B2 (en) | 2011-11-07 | 2022-04-05 | Amarin Pharmaceuticals Ireland Limited | Methods of treating hypertriglyceridemia |
WO2014074552A2 (en) | 2012-11-06 | 2014-05-15 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising ldl-c levels in a subject on concomitant statin therapy |
EP2745706A1 (en) * | 2012-12-24 | 2014-06-25 | Abbott Laboratories, Inc. | Methods for maintaining bone quality |
US20140187633A1 (en) | 2012-12-31 | 2014-07-03 | Amarin Pharmaceuticals Ireland Limited | Methods of treating or preventing nonalcoholic steatohepatitis and/or primary biliary cirrhosis |
US9452151B2 (en) | 2013-02-06 | 2016-09-27 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing apolipoprotein C-III |
US20140271841A1 (en) | 2013-03-15 | 2014-09-18 | Amarin Pharmaceuticals Ireland Limited | Pharmaceutical composition comprising eicosapentaenoic acid and derivatives thereof and a statin |
PL225614B1 (pl) | 2013-10-08 | 2017-04-28 | Zachodniopomorski Univ Tech W Szczecinie | Prozdrowotny produkt spożywczy |
US9585859B2 (en) | 2013-10-10 | 2017-03-07 | Amarin Pharmaceuticals Ireland Limited | Compositions and methods for lowering triglycerides without raising LDL-C levels in a subject on concomitant statin therapy |
US10172818B2 (en) | 2014-06-16 | 2019-01-08 | Amarin Pharmaceuticals Ireland Limited | Methods of reducing or preventing oxidation of small dense LDL or membrane polyunsaturated fatty acids |
MA51766A (fr) | 2018-09-24 | 2020-12-16 | Amarin Pharmaceuticals Ie Ltd | Procédés de réduction du risque d'événements cardiovasculaires chez un sujet |
KR20240012390A (ko) | 2021-04-21 | 2024-01-29 | 애머린 파마슈티칼스 아일랜드 리미티드 | 심부전의 위험을 감소시키는 방법 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2623214C (en) * | 2005-09-30 | 2011-07-26 | Hill's Pet Nutrition, Inc. | Methods for extending the shelf-life of food compositions containing polyunsaturated fatty acids |
US20080076823A1 (en) * | 2006-08-09 | 2008-03-27 | Watkins Bruce A | Methods of improving bone health and muscle health |
CN101433240B (zh) * | 2007-11-16 | 2013-01-16 | 光明乳业股份有限公司 | 一种适合孕妇和乳母食用的牛奶及其制备方法 |
-
2011
- 2011-03-21 EP EP11380021A patent/EP2502506A1/en not_active Withdrawn
-
2012
- 2012-03-20 MX MX2013010831A patent/MX2013010831A/es unknown
- 2012-03-20 CA CA2829794A patent/CA2829794A1/en not_active Abandoned
- 2012-03-20 CN CN201280024423.6A patent/CN103533853A/zh active Pending
- 2012-03-20 US US13/424,847 patent/US20120245121A1/en not_active Abandoned
- 2012-03-20 WO PCT/US2012/029796 patent/WO2012129222A1/en active Application Filing
- 2012-03-20 BR BR112013024189A patent/BR112013024189A2/pt not_active IP Right Cessation
-
2013
- 2013-09-10 IL IL228339A patent/IL228339A0/en unknown
Also Published As
Publication number | Publication date |
---|---|
US20120245121A1 (en) | 2012-09-27 |
BR112013024189A2 (pt) | 2016-12-13 |
CA2829794A1 (en) | 2012-09-27 |
EP2502506A1 (en) | 2012-09-26 |
CN103533853A (zh) | 2014-01-22 |
IL228339A0 (en) | 2013-12-31 |
WO2012129222A1 (en) | 2012-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX2013010831A (es) | Metodo para mejorar la salud osea en los bebes usando los acidos grasos poliinsaturados de cadena larga. | |
MX2013010830A (es) | Metodos para mejorar la salud osea en los bebes usando los prebioticos. | |
EA201201281A1 (ru) | Обогащение диеты матерей сиаловой кислотой | |
MY186188A (en) | Nutritional phytonutrient compositions | |
NZ613165A (en) | Nutritional formulations including human milk oligosaccharides and long chain polyunsaturated fatty acids and uses thereof | |
MY166016A (en) | Infant nutrition for improving fatty acid composition of brain membranes | |
MY191538A (en) | Human milk oligosaccharides to promote growth of beneficial bacteria | |
PH12019550208A1 (en) | Hmos blends for use in infants or young children for health purposes | |
PH12018500090A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
MX350870B (es) | Formula para lactantes con alto palmitato sn-2 y oligofructosa. | |
PL2398527T3 (pl) | Sposób do zastosowania z odciągaczem pokarmu w celu zapoczątkowania wypływu mleka przy karmieniu piersią, w szczególności dla wcześniaków | |
PH12018500035A1 (en) | Nutritional compositions and methods for promoting cognitive development | |
PH12016501952A1 (en) | Nutritional compositions directed to subjects having cow`s milk protein allergies | |
MY175195A (en) | Nutritional compositions | |
PH12016500763A1 (en) | Synthetic milk compositions comprising polyunsaturated fatty acids (pufas) for promoting the healthy establishment of cognitive function in male and female infant and children | |
PH12015502517B1 (en) | Compositions and methods for nutrient delivery | |
NZ604981A (en) | Early programming of brain function through soy protein feeding | |
PH12015500683A1 (en) | Formula fortifier | |
PH12015502054A1 (en) | Prenatal and lactation supplements to enhance central nervous system development of offspring | |
MY169302A (en) | Compositions and methods for nutrient delivery | |
RU2016143827A (ru) | Дифференцированные по полу искусственные питательные композиции и содержащие их системы питания | |
PH22015000587Y1 (en) | A formulation for female breast and buttocks enhancement | |
임지나 et al. | Longitudinal study of iron concentration in Korean preterm human milk | |
UA69863U (ru) | Способ коррекции возрастных изменений кожи у женщин | |
MY146018A (en) | Method for improved breast milk feeding to reduce the risk of allergy |